Abstract
Safety of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease (P2.337)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1212/wnl.86.16_supplement.p2.337
Journal: Neurology | Publication Date: Apr 5, 2016 |
Safety of Sublingual Apomorphine (APL-130277) for the Treatment of OFF Episodes in Patients with Parkinson's Disease (P2.337)
Join us for a 30 min session where you can share your feedback and ask us any queries you have